Vogt-Koyanagi-Harada disease in hispanic patients

International Ophthalmology

Volumn 27, Issue 2-3, 2007, Pages 143-148

  Sukavatcharin, Somsiri ^a,b   Tsai, Julie H ^a,b   Rao, Narsing A ^a,b  

^a DOHENY EYE INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Corticosteroid; Earlyphase VKH; Hispanic; Late phase VKH; Vogt Koyanagi Harada disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; AGED; ALOPECIA; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE DURATION; DISEASE SURVEILLANCE; ETHNIC DIFFERENCE; FEMALE; GLAUCOMA; HEARING DISORDER; HISPANIC; HUMAN; MALE; MEDICAL RECORD REVIEW; MENINGISM; MONOTHERAPY; OCULAR FIBROSIS; OUTCOME ASSESSMENT; PAPILLEDEMA; POLIOMYELITIS; PROGNOSIS; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA PIGMENT EPITHELIOPATHY; SCHOOL CHILD; SUBRETINAL NEOVASCULARIZATION; UVEITIS; VISUAL ACUITY; VITILIGO; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HISPANIC AMERICANS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; UVEOMENINGOENCEPHALITIC SYNDROME; VISUAL ACUITY;

EID: 34250361499     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-006-9017-6     Document Type: Article

References (23)

1. Moorthy RS, Inomata H, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39:265-292
2. Sugiura S (1978) Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 22:9-35
3. Alaez C, del Pilar Mora M, Arellanes L, Cano S, Perez-Luque E, Vazquez MN, et al. 1999 Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease. Hum Immunol 60:875-882
4. Levinson RD, See RF, Rajalingam R, Reed EF, Park MS, Rao NA, et al. (2004) HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol 65:1477-1482
5. Shimizu K (1973) Harada's, Behcet's, Vogt-Koyanagi syndromes - are they clinical entities? Trans Am Acad Ophthalmol Otolarnyngol 77:OP281-OP290
6. Ohno S, Char DH, Kimura SJ, O'Connor GR (1977) Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 83:735-740
7. Snyder DA, Tessler HH (1980) Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 90:69-75
8. Nussenblatt RB (1988) Clinical studies of Vogt-Koyanagi-Harada's disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol 32:330-333
9. Beniz J, Forster DJ, Lean JS, Smith RE, Rao NA (1991) Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 11:275-280
10. Rosen E (1945) Uveitis, with poliosis, vitiligo, alopecia and dysacusia (Vogt-Koyanagi syndrome). Arch Ophthalmol 33:281-292
11. Minakawa R, Ohno S, Hirose S, Kotake S, Miyajima T, Tagawa Y, et al. (1985) Clinical manifestation of Vogt-Koyanagi-Harada's disease. Jpn J Clin Ophthalmol 39:1249-1253
12. Ohno S, Minakawa R, Matsuda H (1988) Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 32:334-343
13. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647-652
14. Bouchenaki N, Herbort CP (2001) The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 108:54-64
15. Rutzen AR, Ortega-Larrocea G, Frambach DA, Rao NA (1995) Macular edema in chronic Vogt-Koyanagi-Harada syndrome. Retina 15:475-479
16. Wallyn RH, Hilton GF (1979) Subretinal fibrosis in retinal detachment. Arch Ophthalmol 97:2128-2129
17. Moorthy RS, Rajeev B, Smith RE, Rao NA (1994) Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 118:197-204
18. Forster DJ, Rao NA, Hill RA, Nguyen QH, Baerveldt G (1993) Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome. Ophthalmology 100:613-618
19. Hayasaka S, Okabe H, Takahashi J (1982) Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 218:9-13
20. Sasamoto Y, Ohno S, Matsuda H (1990) Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 201:162-167
21. Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. (2001) Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131:599-606
22. Rubsamen RE, Gass JDM (1991) Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 109:682-687
23. Keino H, Goto H, Usui M (2002) Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol 240:878-882